Article Details
Retrieved on: 2025-10-03 14:07:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A regimen based on Jazz Pharma and PharmaMar's Zepzelca and Roche's Tecentriq has been approved in the US as a maintenance therapy for ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here